PDF herunterladen
CC BY-NC-ND 4.0 · World J Nucl Med 2021; 20(01): 102-104
DOI: 10.4103/wjnm.WJNM_34_20
Case Report

Graves' disease: A rare fate of Hashimoto's thyroiditis

Rahul Jadhav
Rush University Medical Center, Chicago, IL, USA
,
Mohammad Alberawi
1   Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, IL, USA
,
Khushboo Gupta
1   Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, IL, USA
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Hashimoto's thyroiditis is a known autoimmune disorder that leads to chronic inflammation of the thyroid gland, with a gradual decline in function and eventual hypothyroidism. Conversion of Hashimoto's thyroiditis to Graves' disease is unusual clinically and has been occasionally reported in the literature. Awareness of such a rare phenomenon is important for the physicians evaluating patients with autoimmune thyroid disorders. Close investigation of the patient's symptoms and biochemical status is crucial in the implementation of appropriate treatment.

Keywords

Autoimmune disorder - Graves' disease - Hashimoto's thyroiditis

Financial support and sponsorship

Nil.




Publikationsverlauf

Eingereicht: 07. Juli 2020

Angenommen: 26. Mai 2020

Artikel online veröffentlicht:
30. März 2022

© 2021. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: The Whickham survey. Clin Endocrinol (Oxf) 1977;7:481-93.
  • 2 McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine 2012;42:252-65.
  • 3 Gavras L, Thomson JA. Late thyrotoxicosis complicating autoimmune thyroiditts. Acta Endocrinol 1972;69:44-6.
  • 4 Takasu N, Yamada T, Sato A, Nakagawa M, Komiya I, Nagasawa Y, et al. Graves'' disease following hypothyroidism due to Hashimoto's disease: Studies of eight cases. Clin Endocrinol 1990;33:687-98.
  • 5 Furqan S, Haque NU, Islam N. Conversion of autoimmune hypothyroidism to hyperthyroidism. BMC Res Notes 2014;7:489.
  • 6 Kamath C, Young S, Kabelis K, Sanders J, Adlan MA, Furmaniak J, et al. Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto's who developed Graves'' disease and pretibial myxoedema. Clin Endocrinol (Oxf) 2012;77:465-70.
  • 7 Latif R, Yin X. New genetic insights from autoimmune thyroid disease. J Thyroid Res 2012;2012:623852.
  • 8 Gupta K, Jadhav R, Prasad R, Virmani R, Singh J, Ali A, et al. Variable 18F FDG uptake patterns in thyroid disorders and its correlative imaging a case based pictorial review. J Nucl Med 2017;58:1003.
  • 9 Małkowski B, Serafin Z, Glonek R, Suwała S, Łopatto R, Junik R. The role of 18F-FDG PET/CT in the management of the autoimmune thyroid diseases. Front Endocrinol (Lausanne) 2019;10:208.